https://www.pharmaceutical-technology.com/sector/therapy-area/immunology/ The leading site for news and procurement in the pharmaceutical industry Fri, 12 Apr 2024 13:50:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png https://www.pharmaceutical-technology.com/sector/therapy-area/immunology/ 32 32 https://www.pharmaceutical-technology.com/news/century-secures-60m-in-stock-sale-and-buys-preclinical-cell-therapy-biotech/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2119416338-1.jpg Fri, 12 Apr 2024 13:50:52 +0000 https://www.pharmaceutical-technology.com/news/century-secures-60m-in-stock-sale-and-buys-preclinical-cell-therapy-biotech/ https://www.pharmaceutical-technology.com/news/eliem-to-acquire-tenet/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Eliem.jpg Fri, 12 Apr 2024 10:08:37 +0000 https://www.pharmaceutical-technology.com/news/eliem-to-acquire-tenet/ https://www.pharmaceutical-technology.com/news/vertex-joins-pharma-immunotherapy-deal-uptick-with-4-9bn-alpine-purchase/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2194157701.jpg Thu, 11 Apr 2024 15:02:27 +0000 https://www.pharmaceutical-technology.com/news/vertex-joins-pharma-immunotherapy-deal-uptick-with-4-9bn-alpine-purchase/ https://www.pharmaceutical-technology.com/news/fda-approves-alexion-nmosd-ultomiris/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/Alexion.jpg Tue, 26 Mar 2024 08:10:18 +0000 https://www.pharmaceutical-technology.com/news/fda-approves-alexion-nmosd-ultomiris/ https://www.pharmaceutical-technology.com/news/abbvie-acquires-landos-biopharma/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/abbvie.jpg Tue, 26 Mar 2024 07:58:33 +0000 https://www.pharmaceutical-technology.com/news/abbvie-acquires-landos-biopharma/ https://www.pharmaceutical-technology.com/news/mirador-launch-precision-therapies/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/Mirador.jpg Fri, 22 Mar 2024 08:31:12 +0000 https://www.pharmaceutical-technology.com/news/mirador-launch-precision-therapies/ https://www.pharmaceutical-technology.com/news/capstan-car-t-therapy-development/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/Capstan.jpg Thu, 21 Mar 2024 11:00:33 +0000 https://www.pharmaceutical-technology.com/news/capstan-car-t-therapy-development/ https://www.pharmaceutical-technology.com/news/alumis-259m-immune-dysfunction-therapies/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/Alumis.jpg Thu, 07 Mar 2024 08:02:35 +0000 https://www.pharmaceutical-technology.com/news/alumis-259m-immune-dysfunction-therapies/ https://www.pharmaceutical-technology.com/analyst-comment/shifting-the-paradigm-novel-approaches-to-amyotrophic-lateral-sclerosis-therapy/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_2340940201.jpg Thu, 29 Feb 2024 13:53:36 +0000 https://www.pharmaceutical-technology.com/analyst-comment/shifting-the-paradigm-novel-approaches-to-amyotrophic-lateral-sclerosis-therapy/ https://www.pharmaceutical-technology.com/news/abbvie-licenses-oses-chronic-inflammation-therapy-for-48m-upfront/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_2408719257.jpg Wed, 28 Feb 2024 16:24:37 +0000 https://www.pharmaceutical-technology.com/news/abbvie-licenses-oses-chronic-inflammation-therapy-for-48m-upfront/